Cardiovascular effects of biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs).
Sign Up to like & getrecommendations! Published in 2020 at "Current vascular pharmacology"
DOI: 10.2174/1570161118666200214115532
Abstract: The risk of cardiovascular (CV) disease is increased among patients with systemic autoimmune rheumatic diseases and remains an underserved area of medical need. Although traditional risk factors for CV disease, such as hypertension, smoking, dyslipidemia… read more here.
Keywords: risk; effects biologic; disease modifying; disease ... See more keywords